Skip to content
PubMed This is a summary of 11 peer-reviewed journal articles Updated
Endocrinology

How Does Acromegaly Affect Fertility and Pregnancy?

At a Glance

Acromegaly can cause infertility, but many women can successfully get pregnant once the disease and IGF-1 levels are managed. While pregnancy is generally safe, it requires close monitoring by an endocrinologist and high-risk OB/GYN for gestational diabetes, high blood pressure, and tumor growth.

Yes, acromegaly can disrupt fertility, but with specialized care, many women with this condition can successfully get pregnant and have healthy babies. About half of women with acromegaly experience some degree of infertility or subfertility [1]. However, once your condition is managed and tumor size is controlled, fertility often returns, and pregnancy is generally considered safe for both mother and baby [2][3][4].

How Acromegaly Affects Fertility

Acromegaly usually impacts fertility in two main ways, both related to the size and activity of the pituitary tumor:

  • Hypogonadotropic Hypogonadism (Central Hypogonadism): A large pituitary tumor can physically press against the healthy parts of the pituitary gland [5][6]. This pressure stops the gland from releasing the hormones necessary to trigger ovulation and maintain a regular menstrual cycle.
  • Hyperprolactinemia: In about one-third of acromegaly cases, there is an abnormal increase in prolactin, the hormone normally responsible for breast milk production [5][7][1]. When prolactin levels are inappropriately high, it signals the body to stop ovulating.

The key to restoring fertility is getting the disease under control. Growth hormone (GH) triggers your body to produce Insulin-like Growth Factor 1 (IGF-1), the primary marker used to track your acromegaly [1]. Achieving normal hormone levels and reducing the tumor size—typically through surgery or medical therapy—can often restore regular menstrual cycles [4][1]. If natural conception does not happen after treatment, assisted reproductive therapies (like IVF) or ovulation-stimulating medications are effective options [1].

Planning for Pregnancy

Before trying to conceive, it is highly recommended to seek pre-pregnancy counseling with a multidisciplinary care team, which should include your endocrinologist and a maternal-fetal medicine (high-risk OB/GYN) specialist [8][4].

The goal of this planning phase is to optimize your IGF-1 levels and control the tumor’s size before pregnancy [8][4]. Doing so is the most effective way to minimize risks for both you and your baby during gestation.

Risks and Monitoring During Pregnancy

If you become pregnant, the outcomes for the baby (such as birth weight and healthy development) are generally just as favorable as they are for mothers without acromegaly [2][3][4]. Furthermore, acromegaly is rarely inherited, meaning it is highly unlikely you will pass the condition to your child.

However, pregnancy with acromegaly does carry increased maternal risks that require close monitoring:

  • Metabolic and Blood Pressure Risks: Pregnant women with acromegaly have a higher chance of developing gestational diabetes (high blood sugar that starts during pregnancy) and pregnancy-induced hypertension or preeclampsia (dangerously high blood pressure) [9][10][4]. The best predictor of whether you will develop these conditions is how well your IGF-1 levels are controlled right at the moment you conceive [1].
  • Tumor Growth: It is rare for a pituitary tumor to expand symptomatically during pregnancy, happening in 0 to 9% of cases [1]. Because standard blood tests for GH and IGF-1 can be difficult to interpret during pregnancy (the placenta naturally produces its own growth hormone), doctors rely heavily on monitoring your physical symptoms [1]. Your care team will watch closely for signs of tumor growth, such as new headaches or changes in your peripheral vision [1].

Medication Adjustments

Managing acromegaly during pregnancy requires a careful balance. Medical guidelines generally recommend stopping therapies such as somatostatin analogs (like octreotide or lanreotide), dopamine agonists (like cabergoline), and GH receptor antagonists (like pegvisomant) either before trying to conceive or as soon as pregnancy is confirmed [9][11][1].

Warning: Never stop, start, or change your medications without consulting your endocrinologist first.

If your tumor begins to grow or if you develop severe symptoms during your pregnancy, your doctor may decide to restart certain medications. Available evidence indicates that using these therapies during pregnancy to control tumor expansion is generally safe when medically necessary [9][11][1].

Postpartum Care and Breastfeeding

After delivery, your body goes through rapid hormonal changes, making a prompt postpartum reassessment of your disease and IGF-1 levels essential [1].

If you wish to breastfeed, discuss your options with your doctor. Available data suggests that certain medications, like somatostatin analogs, may be safe to use during lactation [1]. Your endocrinologist will help you weigh the benefits of breastfeeding against your need to resume acromegaly treatment.

Common questions in this guide

Can I get pregnant if I have acromegaly?
Yes, many women with acromegaly can successfully get pregnant and have healthy babies. Achieving normal hormone levels and reducing tumor size is the most effective way to restore regular menstrual cycles and improve fertility.
Why does acromegaly cause infertility?
A large pituitary tumor can physically press against healthy tissue, preventing the release of hormones necessary for ovulation. Additionally, acromegaly often causes an abnormal increase in prolactin, a hormone that signals the body to stop ovulating.
Will I pass acromegaly to my baby?
Acromegaly is rarely inherited, meaning it is highly unlikely that you will pass the condition to your child. Outcomes for the baby, including birth weight and healthy development, are generally just as favorable as they are for mothers without the condition.
Do I need to stop my acromegaly medication when I get pregnant?
Medical guidelines generally recommend pausing acromegaly medications before trying to conceive or as soon as pregnancy is confirmed. You should never stop or change your medication without consulting your endocrinologist, as they may need to monitor your symptoms closely.
What are the risks of pregnancy with acromegaly?
Pregnant women with acromegaly face a higher risk of developing gestational diabetes and pregnancy-induced hypertension. Though rare, your doctor will also monitor you closely for signs of tumor growth, such as new headaches or changes in your peripheral vision.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What are my current IGF-1 levels, and are they optimal for attempting pregnancy?
  2. 2.Should I consider surgery to further reduce my tumor size before trying to conceive?
  3. 3.Which of my current acromegaly medications will I need to pause, and exactly when should I stop taking them?
  4. 4.How frequently will my vision and symptoms be monitored while I am pregnant?
  5. 5.Can you recommend a maternal-fetal medicine specialist (high-risk OB/GYN) to join my care team?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (11)
  1. 1

    Approach of Acromegaly during Pregnancy.

    Popescu AD, Carsote M, Valea A, et al.

    Diagnostics (Basel, Switzerland) 2022; (12(11)) doi:10.3390/diagnostics12112669.

    PMID: 36359512
  2. 2

    Acromegaly and pregnancy: a systematic review and meta-analysis.

    Bandeira DB, Olivatti TOF, Bolfi F, et al.

    Pituitary 2022; (25(3)):352-362 doi:10.1007/s11102-022-01208-0.

    PMID: 35098440
  3. 3

    Course and outcomes of pregnancy in women treated for acromegaly: Discerning a contemporary cohort.

    Das L, Dutta P, Thirunavukkarasu B, et al.

    Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2021; (60-61()):101417 doi:10.1016/j.ghir.2021.101417.

    PMID: 34271296
  4. 4

    Pregnancy in acromegaly is safe and is associated with improvements in IGF-1 concentrations.

    Hannon AM, O'Shea T, Thompson CA, et al.

    European journal of endocrinology 2019; (180(4)):K21-K29.

    PMID: 30620709
  5. 5

    Female gonadal functions and ovarian reserve in patients with acromegaly: experience from a single tertiary center.

    Dogansen SC, Tanrikulu S, Yalin GY, Yarman S

    Endocrine 2018; (60(1)):167-174 doi:10.1007/s12020-018-1540-5.

    PMID: 29404901
  6. 6

    Trabecular bone score as a skeletal fragility index in acromegaly patients.

    Hong AR, Kim JH, Kim SW, et al.

    Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2016; (27(3)):1123-1129 doi:10.1007/s00198-015-3344-2.

    PMID: 26446771
  7. 7

    Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 2, specific diseases.

    Korbonits M, Blair JC, Boguslawska A, et al.

    Nature reviews. Endocrinology 2024; (20(5)):290-309 doi:10.1038/s41574-023-00949-7.

    PMID: 38336898
  8. 8

    MANAGEMENT OF ENDOCRINE DISEASE: Acromegaly and pregnancy: a contemporary review.

    Abucham J, Bronstein MD, Dias ML

    European journal of endocrinology 2017; (177(1)):R1-R12.

    PMID: 28292926
  9. 9

    An update on clinical care for pregnant women with acromegaly.

    Chanson P, Vialon M, Caron P

    Expert review of endocrinology & metabolism 2019; (14(2)):85-96 doi:10.1080/17446651.2019.1571909.

    PMID: 30696300
  10. 10

    Safety of pregnancy in acromegaly patients and maternal and infant outcomes after pregnancy: single-center experience from China and review of the literature.

    Jiao R, Ju J, Wang L, et al.

    BMC endocrine disorders 2023; (23(1)):104 doi:10.1186/s12902-023-01341-2.

    PMID: 37161564
  11. 11

    First-generation somatostatin receptor ligands and pregnancy: lesson from women with acromegaly.

    Vialon M, Grunenwald S, Mouly C, et al.

    Endocrine 2020; (70(2)):396-403 doi:10.1007/s12020-020-02430-1.

    PMID: 32734551

This page is for informational purposes only and does not replace professional medical advice. Always consult your endocrinologist and maternal-fetal medicine specialist before trying to conceive, or before starting or stopping any medications.

Get notified when new evidence is published on Acromegaly.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.